Alphamab Oncology is a company focused on the development, manufacture and commercialization of innovative tumor immunobiomolecular targeting drugs in the entire industry chain. The company has built an anti-tumor product pipeline, of which four new drugs have entered the Phase I-III clinical trial development phase. It was founded in 2015, and headquartered in Suzhou City, China.
Headquarters
No. 175 Fangzhou Road, Suzhou Industrial Park, Suzhou
Suzhou; Jiangsu;
Contact Details: Purchase the Alphamab Oncology (康宁杰瑞生物制药) report to view the information.
Website: http://www.alphamabonc.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service